Another Biologic Reduces COPD Exacerbations

MedPage Today) — Mepolizumab (Nucala) helped prevent exacerbations of chronic obstructive pulmonary disease (COPD) when added to background triple inhaled therapy among patients with an eosinophilic phenotype, the phase III MATINEE trial showed…